肝胆类器官及其在肝脏健康与疾病研究中的应用:我们准备好了吗?
该综述总结了现有成体细胞来源的肝胆类器官模型及其应用。肝细胞类器官用于研究Alagille综合征、脂肪肝、Wilson病、乙肝病毒感染和囊性纤维化;胆管细胞类器官用于研究正常胆管生物学、原发性硬化性胆管炎及体外形成胆管和胆囊组织;肿瘤类器官用于药物测试和癌症样本生物样本库。文章还讨论了细胞不成熟、共培养开发、细胞外基质不完善及缺乏标准化协议和模型验证等挑战。
要点
- 肝细胞类器官可用于研究Alagille综合征、脂肪肝、Wilson病、乙肝和囊性纤维化。
- 胆管细胞类器官用于研究正常胆管生物学、原发性硬化性胆管炎及体外胆管形成。
- 肝胆肿瘤类器官可作为药物测试平台和癌症样本生物样本库,并可通过CRISPR构建致癌模型。
核心结论
- 肝胆类器官技术已用于多种肝脏和胆管疾病研究及药物测试,但仍面临细胞不成熟、共培养、细胞外基质和标准化等挑战。
研究设计与样本
- 综述总结了目前可用的成体细胞来源的肝胆类器官模型及其应用。
主要发现
- 肝细胞类器官已用于研究Alagille综合征、脂肪肝疾病、Wilson病、乙肝病毒感染和囊性纤维化。
- 胆管细胞类器官已建立用于研究正常胆管细胞生物学和原发性硬化性胆管炎,并测试体外形成胆管和胆囊组织的潜力。
- 肝胆肿瘤类器官已从冷冻和新鲜人组织建立,用作药物测试平台和癌症样本生物样本库。
- 基于CRISPR的基因修饰和类器官暴露于感染因子已允许生成致癌类器官模型。
临床怎么用
- 肝胆类器官可用于疾病建模、药物测试和癌症样本生物样本库,但需注意当前技术的局限性。
局限性
- 类器官来源的肝细胞存在细胞不成熟问题。
- 需要开发共培养以更好地模拟复杂组织结构。
- 细胞外基质不完善。
- 缺乏标准化协议和模型验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Organoid culture systems have emerged as a frontier technology in liver and biliary research. These three-dimensional (3D) cell cultures derived from pluripotent and adult hepatobiliary cells model organ structure and function. Building on gastrointestinal organoid establishment, hepatobiliary organoid cultures were generated from mouse leucine-rich repeat-containing G-protein-coupled receptor 5-positive liver progenitor cells. Subsequently, 3D hepatobiliary organoid cultures were developed from hepatocytes and cholangiocytes to model human and animal hepatobiliary health and disease. Hepatocyte organoids have been used to study Alagille syndrome, fatty liver disease, Wilson disease, hepatitis B viral infection, and cystic fibrosis. Cholangiocyte organoids have been established to study normal cholangiocyte biology and primary sclerosing cholangitis and to test organoid potential to form bile ducts and gallbladder tissue in vitro. Hepatobiliary cancer organoids, termed tumoroids, have been established from frozen and fresh human tissues and used as a drug-testing platform and for biobanking of cancer samples. CRISPR-based gene modifications and organoid exposure to infectious agents have permitted the generation of organoid models of carcinogenesis. This review summarizes currently available adult cell-derived hepatobiliary organoid models and their applications. Challenges faced by this young technology will be discussed, including the cellular immaturity of organoid-derived hepatocytes, co-culture development to better model complex tissue structure, the imperfection of extracellular matrices, and the absence of standardized protocols and model validation.
引用
- Shiota J, Samuelson LC, Razumilava N, et al. Hepatobiliary Organoids and Their Applications for Studies of Liver Health and Disease: Are We There Yet? Hepatology. 2021. PMID: 33638203. doi:10.1002/hep.31772
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。